The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor–positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.
 
Peter A. Fasching
Honoraria - Agendia; AstraZeneca; BionTech (Inst); Cepheid (Inst); Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst); Roche
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Vanesa Quiroga
Consulting or Advisory Role - Ferrer (Inst)
Speakers' Bureau - Roche (Inst)
Research Funding - Roche
 
Yeon Hee Park
Honoraria - Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Gencurix (Inst); Novartis; Pfizer; Roche (Inst)
 
Isabel Blancas
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Kyowa Kirin; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Veracyte
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Veracyte
Research Funding - AstraZeneca Spain (Inst); F. Hoffmann LaRoche; Lilly Medical; Roche (Inst)
Other Relationship - Fundación San Juan de Dios, Adknoma
 
Jose Luis Alonso
Research Funding - Roche
 
Alexander Vasilyev
No Relationships to Disclose
 
Hryhoriy Adamchuk
Research Funding - Roche
 
Marcelo Ramos Tejo Salgado
No Relationships to Disclose
 
Denise A. Yardley
Consulting or Advisory Role - Athenex (Inst); Biotheranostics (Inst); G1 Therapeutics (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Research Funding - Abbvie (Inst); Ambrx (Inst); Amgen (Inst); Biomarin (Inst); Biothera (Inst); Clovis Oncology (Inst); Dana Farber Cancer Hospital (Inst); Genentech/Roche (Inst); Incyte (Inst); Innocrin Pharma (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); NSABP Foundation (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Polyphor (Inst); Tesaro (Inst)
 
Gonzalo Spera
No Relationships to Disclose
 
Cloris Xue
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Erika Ferreira
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Tanja Badovinac Crnjevic
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Pablo Diego Pérez-Moreno
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Vanesa López-Valverde
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Jutta Steinseifer
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Tharu M. Fernando
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Heather M. Moore
Employment - Genentech; Pfizer (I)
Stock and Other Ownership Interests - Roche
 
Sara A. Hurvitz
Stock and Other Ownership Interests - Ideal Implant (I); ROM Tech (I)
Research Funding - Ambryx (Inst); Amgen (Inst); Arvinas (Inst); Bayer (Inst); Biomarin (Inst); Cascadian Therapeutics (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dignitana (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Phoenix Molecular Designs (Inst); Pieris Pharmaceuticals (Inst); Puma Biotechnology (Inst); Radius Health (Inst); Samumed (Inst); sanofi (Inst); Seagen (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Lilly
Other Relationship - Pfizer; Roche